Healthy Living/WellnessGout Drug Lesinurad By AstraZeneca Receives Approval Recommendation From FDA Advisory Committee Lesinurad is a step closer towards achieving FDA approval as the agency’s Arthritis Advisory Committee has recommended that the drug be approved for use in the U.S.by Dianne Depra
Healthy Living/WellnessFDA Gives AstraZeneca Brilinta Nod Of Approval For Longer-Term Useby Dianne Depra
Healthy Living/WellnessAstraZeneca To Pay Inovio $727.5 Million For Experimental Cancer Drugby Rhodi Lee
Healthy Living/WellnessAstraZeneca-Lilly Collaboration To Test New Combination Of Cancer Drugsby Dianne Depra
Healthy Living/WellnessAstraZeneca Heart Drug Brilinta May Benefit Heart Patients But Carries Risksby James Maynard
Healthy Living/WellnessFDA approves AstraZeneca's EPANOVA, adjunct to diet for people with very high triglyceride levelsby Anne Francis
Leader of Furry Hackers Raided by Feds Months After Attack on Creators of Project 2025, Former Member Claims